| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-07 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-06 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |